Zomedica Corp. (ZOMDF)
↓ Download CSV- Sector Manufacturing
- Incorporated A0
- Fiscal year ends Dec 31
In fiscal 2025, Zomedica Corp. reported revenue of $32.03M, up 17.4% from the prior year. The company ran a net loss, with a net margin of -255.6% and a gross margin of 67.7%. It held $127.04M in total assets against $11.64M in total liabilities.
Key ratios (FY2025)
67.7%
Gross margin
-263.4%
Operating margin
-255.6%
Net margin
-70.9%
Return on equity
+17.4%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $32.03M | $27.29M | $25.19M | $18.93M | $4.13M | $0 | — | — | — | — |
| Cost of Revenue | $10.35M | $8.20M | $7.87M | $5.46M | $1.08M | $0 | — | — | — | — |
| Gross Profit | $21.68M | $19.09M | $17.32M | $13.47M | $3.05M | $0 | — | — | — | — |
| Operating Income | -$84.35M | -$51.05M | -$43.27M | -$21.92M | -$21.37M | -$16.76M | -$19.78M | -$16.58M | -$8.08M | -$5.73M |
| Net Income | -$81.86M | -$46.98M | -$34.53M | -$17.02M | -$18.38M | -$16.91M | -$19.78M | -$16.65M | -$8.07M | -$5.74M |
| EPS (Diluted) | $-0.08 | $-0.05 | $-0.04 | $-0.02 | — | — | — | — | — | — |
| Total Assets | $127.04M | $207.36M | $253.20M | $279.61M | $280.40M | $66.14M | $4.18M | $6.03M | $5.22M | $4.58M |
| Total Liabilities | $11.64M | $11.70M | $13.18M | $12.22M | $9.51M | $3.12M | $2.09M | — | — | — |
| Shareholders' Equity | $115.40M | $195.66M | $240.02M | $267.39M | $270.89M | $51.07M | $2.10M | $3.66M | $4.39M | $3.83M |
| Cash & Equivalents | $9.02M | $7.02M | $12.95M | $27.40M | $194.95M | $61.99M | $510.6K | $1.94M | $3.45M | $3.23M |
| Operating Cash Flow | -$17.65M | -$23.63M | -$15.97M | -$11.67M | -$14.28M | -$16.24M | -$15.63M | -$11.15M | -$7.09M | -$4.56M |
| Capital Expenditures | $567.0K | $5.21M | $11.34M | $787.0K | $147.0K | $14.8K | $155.5K | $628.0K | $171.7K | $231.6K |
| Shares Outstanding | 979.95M | 979.95M | 979.95M | 979.95M | 979.90M | 642.04M | 108.04M | 97.60M | 90.23M | 83.96M |